My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Clene Inc. - Common Stock (NQ:CLNN)

4.230 +0.120 (+2.92%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Clene Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 17, 2024

It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!

Via InvestorPlace

Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket ↗

April 17, 2024

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 16, 2024

Via Benzinga

Breaking Down Clene: 4 Analysts Share Their Views ↗

March 13, 2024

Via Benzinga

Clene: Q4 Earnings Insights ↗

March 13, 2024

Via Benzinga

Clene Inc. announces positive results from CNM-Au8 results from MS trial

February 05, 2024

--News Direct--

Via News Direct

Expert Ratings for Clene ↗

September 21, 2023

Via Benzinga

3 Penny Stocks That Could Be Multibaggers in the Making: March Edition ↗

March 26, 2024

Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while.

Via InvestorPlace

Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 14, 2024

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 13, 2024

Via Benzinga

Where Clene Stands With Analysts ↗

August 14, 2023

Via Benzinga

7 Underappreciated Penny Stocks That Pack a Wallop ↗

February 12, 2024

Although extreme speculation inherently attracts astounding risks, these underappreciated penny stocks could beat the odds.

Via InvestorPlace

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

Nasdaq Gains 100 Points; CarMax Earnings Top Views ↗

December 21, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76....

Via Benzinga

Topics Stocks

FDA Refuses Neurology-Focused Clene's Accelerated Approval For Amyotrophic Lateral Sclerosis Treatment, Shares Fall ↗

December 21, 2023

Clene Inc (NASDAQ: CLNN) provided an amyotrophic lateral sclerosis (ALS) regulatory update from its recent meeting with the FDA to discuss CNM-Au8 for ALS, presenting initial clinical and Neurofilament...

Via Benzinga

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 21, 2023

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 21, 2023

Via Benzinga

Crude Oil Moves Lower; Micron Issues Strong Forecast ↗

December 21, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The...

Via Benzinga

Topics Stocks

Dow Jumps 250 Points; US Weekly Jobless Claims Edge Higher ↗

December 21, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.72% to 37,348.90 while the NASDAQ rose 0.96%...

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 21, 2023

It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 05, 2023

Via Benzinga

Clene's Neurogenerative Candidate Shows Potential For Improved Long-Term Survival ↗

September 25, 2023

Clene Inc. (NASDAQ: CLNN) released long-term follow-up data for patients treated with CNM-Au8 30mg for up to 133 weeks in the

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 25, 2023

Via Benzinga

Clene And 2 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

June 28, 2023

The Dow Jones closed higher by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Uber To Rally Around 55%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

June 21, 2023

Rosenblatt boosted the price target for Lumentum Holdings Inc. (NASDAQ: LITE) from $48 to $67. Rosenblatt analyst Mike Genovese maintained a Neutral rating. Lumentum shares fell 1.3% to $60.56 in...

Via Benzinga

Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June ↗

June 16, 2023

U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P...

Via Benzinga

Clene's CNM-Au8 Shows Significant Reduction In Neurodegenerative Biomarker, Raises $40M Via Equity ↗

June 16, 2023

Clene Inc (NASDAQ: CLNN) reported new data demonstrating a statistically significant reduction of plasma neurofilament light chain (NfL) levels for CNM-Au8 treated participants compared to placebo...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.